Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial.
Van den Begin R, Engels B, Boussaer M, Dhont J, Burghelea M, Depuydt T, Poels K, Collen C, Gevaert T, Verellen D, Storme G, de Mey J, De Ridder M.
Van den Begin R, et al.
Radiother Oncol. 2016 Jun;119(3):519-24. doi: 10.1016/j.radonc.2016.04.020. Epub 2016 May 11.
Radiother Oncol. 2016.
PMID: 27179921
Clinical Trial.